ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 127 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $629,000 | +7.7% | 430,708 | +4.8% | 0.00% | +50.0% |
| Q4 2016 | $584,000 | -17.9% | 410,946 | +1.2% | 0.00% | -33.3% |
| Q3 2016 | $711,000 | +158.5% | 406,211 | +152.3% | 0.00% | +200.0% |
| Q2 2016 | $275,000 | -13.2% | 161,031 | +5.5% | 0.00% | 0.0% |
| Q1 2016 | $317,000 | +4.6% | 152,604 | -4.2% | 0.00% | 0.0% |
| Q4 2015 | $303,000 | +1.0% | 159,227 | +1.5% | 0.00% | 0.0% |
| Q3 2015 | $300,000 | -58.8% | 156,944 | 0.0% | 0.00% | -66.7% |
| Q2 2015 | $728,000 | -5.8% | 156,944 | -11.2% | 0.00% | 0.0% |
| Q1 2015 | $773,000 | +32.8% | 176,790 | +5.3% | 0.00% | +50.0% |
| Q4 2014 | $582,000 | -17.9% | 167,813 | -0.8% | 0.00% | -33.3% |
| Q3 2014 | $709,000 | -28.5% | 169,226 | +0.0% | 0.00% | -25.0% |
| Q2 2014 | $991,000 | +0.5% | 169,193 | +0.4% | 0.00% | 0.0% |
| Q4 2013 | $986,000 | +8.0% | 168,497 | -2.7% | 0.00% | 0.0% |
| Q3 2013 | $913,000 | -28.1% | 173,154 | +5.0% | 0.00% | -42.9% |
| Q2 2013 | $1,270,000 | – | 164,892 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $5,085,000 | 1.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,369,066 | $25,603,000 | 1.03% |
| Lyons Wealth Management, LLC. | 56,775 | $334,000 | 0.30% |
| Callan Capital, LLC | 66,118 | $387,000 | 0.10% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 383,050 | $2,245,000 | 0.06% |
| FCG ADVISORS, LLC | 10,600 | $62,000 | 0.05% |
| OppenheimerFunds, Inc. | 7,000,000 | $41,020,000 | 0.04% |
| NEXT Financial Group, Inc | 19,704 | $86,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 27,893,387 | $163,455,000 | 0.04% |
| MURPHY CAPITAL MANAGEMENT INC | 45,000 | $263,000 | 0.04% |